AzTrials
AzTrials

Solid Tumor (Excluding CNS)Pulmojet 3NCT07408375

Effect of a Driving Pressure Adjustment Procedure for High-Frequency Jet Ventilation in Patients Undergoing Tumor Thermal Ablation in Interventional Radiology

A study testing High-Frequency Jet Ventilation (HFJV) in people with Solid Tumor (Excluding CNS), run by Nantes University Hospital at 7 sites in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Tumor thermal ablation under Jet Ventilation is a procedure performed under general anesthesia that enables tumor ablation under radiological imaging guidance. This procedure, being less invasive than conventional surgery, allows for a faster recovery and hospital discharge. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Solid Tumor (Excluding CNS)
What is being tested?
High-Frequency Jet Ventilation (HFJV)
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
560 participants
Where
7 sitesFrance
Study dates
13 Mar 2026to 13 Mar 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age ≥ 18 years.
  • Patient undergoing thermal ablation of a solid tumor under HFJV.
  • Patient who has given their consent.
  • Patient covered by a social security scheme.

Who cannot join

  • Patient under guardianship or curatorship.
  • Patient who does not understand French.
  • Pregnant and breastfeeding woman
  • Patient who has had a pneumonectomy
  • Patient requiring an endotracheal tube smaller than 6.5

Trial locations and contacts

7 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Nathalie DESFRICHES-DORIA contact

0244768434

nathalie.desfrichesdoria@chu-nantes.fr

7 sites in 1 country

France7 sites, 7 recruiting
  • CHU de Lyon

    Lyon, 69002

    Stéphanie CLERC, 0472118088, stephanie.clerc@chu-lyon.fr

    Stéphanie CLERC

    Recruiting
  • CHU de Nantes

    Nantes, 44093

    Nathalie DESFRICHES-DORIA, 0244768434, nathalie.desfrichesdoria@chu-nantes.fr

    Nathalie DESFRICHES-DORIA

    Recruiting
  • CHU de Nîmes

    Nîmes, 30900

    Natacha SIMON-MONNIER, 0466686868, natacha.simon@chu-nimes.fr

    Natacha SIMON-MONNIER

    Not yet recruiting
  • Hôpital Européen Georges Pompidou (HEGP)

    Paris, 75015

    Guillaume HERAUD, 0156093011, heraudg@hotmail.com

    Guillaume HERAUD

    Not yet recruiting
  • CHU de Poitiers

    Poitiers, 86000

    Anne MERCIER, 0615052500, anne.mercier@chu-poitiers.fr

    Anne MERCIER

    Recruiting
  • ICO Unicancer

    Saint-Herblain, 44800

    Roland MARTIN, 0240679900, roland.martin@ico-unicancer.fr

    Roland MARTIN

    Recruiting
  • Institut Gustave Roussy

    Villejuif, 94800

    Sandrine GARDE, 0142116724, sandrine.garde@gustaveroussy.fr

    Sandrine GARDE

    Recruiting

Other trials in France

About this study

Official title: Effect of a Driving Pressure Adjustment Procedure for High-Frequency Jet Ventilation in Patients Undergoing Tumor Thermal Ablation in Interventional Radiology - A Randomized, Controlled, Multicenter Study

Tumor thermal ablation under Jet Ventilation is a procedure performed under general anesthesia that enables tumor ablation under radiological imaging guidance.

This procedure, being less invasive than conventional surgery, allows for a faster recovery and hospital discharge. This procedure requires significant precision to ensure the most complete destruction of the tumor, while also preserving adjacent organs. During general anesthesia, respiratory movements complicate radiological localization and tumor destruction.

Read more

The principle of High-Frequency Jet Ventilation (HFJV) involves using a device that ventilates a small volume of air and oxygen at a specific pressure, called driving pressure, at a high frequency.

This ventilation mode reduces respiratory movements while ensuring continuous ventilation and oxygenation. This respiratory stability allows for the precision necessary to superimpose images for tumor localization and destruction.

There are no guidelines regarding the driving pressure setting for HFJV for tumor thermal ablation. The method tested in this research is based on patient's height to optimize the driving pressure when using HFV.

The main objective of this research is to evaluate the impact of driving pressure settings, on respiratory function, taking into account patient's height.

On the day of the procedure, the driving pressure setting for the HFJV will be randomly assigned (1.4 bars, 1.9 bars, 2.4 bars, or customized according to the patient's height) (1 bar = 14 psi).

The research will be conducted using medical data collected during routine patient care. Patient participation will last for the duration of their hospital stay, approximately two days.

Read the detailed description

Tumor thermal ablation under Jet Ventilation is a procedure performed under general anesthesia that allows for the destruction of a tumor under radiological imaging guidance.

This procedure, less invasive than conventional surgery, allows for a faster recovery and return home. This procedure requires significant precision to ensure the most complete destruction of the tumor, while also preserving organs near the lesion. During general anesthesia, respiratory movements complicate radiological localization and tumor destruction.

The principle of High-Frequency Jet Ventilation (HFJV) involves using a device that ventilates a small volume of air and oxygen at a specific pressure, called driving pressure, at a high frequency.

This ventilation mode reduces respiratory movements while ensuring continuous ventilation and oxygenation. This respiratory stability allows for the precision necessary to superimpose images for tumor localization and destruction.

There are no recommendations regarding the driving pressure setting for HFJV for tumor thermal ablation. The method tested in this research is based on patient's height to optimize the driving pressure when using HFV.

The main objective of this research is to evaluate the impact of driving pressure settings, on respiratory function, taking into account patient's height.

On the day of the procedure, the driving pressure setting for the HFJV will be randomly assigned (1.4 bars, 1.9 bars, 2.4 bars, or customized according to the patient's height).

The research will be conducted using medical data collected during patient care. Patient participation will last for the duration of their hospital stay, approximately two days.

Being tested
High-Frequency Jet Ventilation (HFJV)
Keywords
Ventilation, High-Frequency Jet Ventilation, Anesthesia, Interventional Radiology, Tumor ablation
Medical subject headings
Respiratory Aspiration

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • High-Frequency Jet Ventilation (HFJV)Procedure or surgery

    High-Frequency Jet Ventilation (HFJV) involves ventilating with a small tidal volume of gas at a high frequency, ensuring diaphragmatic stability. This stability allows for the precise superimposition of localization and puncture images.

    HFJV is defined as a ventilation mode with very high insufflation rates (120 to 200 cycles per minute) delivering a low tidal volume through a catheter with a gauge of 13G to 16G.

Study groups in NCT07408375
Study groupRoleWhat they receive
Driving pressure with a fixed setting of 1.4 barsActive comparatorOn the day of the interventional radiology surgery (Day 0), the driving pressure setting will be of 1.4 bars.
Receives: Procedure: High-Frequency Jet Ventilation (HFJV)
Driving pressure with a fixed setting of 1.9 barsActive comparatorOn the day of the interventional radiology surgery (Day 0), the driving pressure setting will be of 1.9 bars.
Receives: Procedure: High-Frequency Jet Ventilation (HFJV)
Driving pressure with a fixed setting of 2.4 barsActive comparatorOn the day of the interventional radiology surgery (Day 0), the driving pressure setting will be of 2.4 bars.
Receives: Procedure: High-Frequency Jet Ventilation (HFJV)
Driving pressure with a personalized settingExperimentalOn the day of the interventional radiology surgery (Day 0), the driving pressure setting will be personalized according to the patient's height : 1.4 bars if patient's height < 150 cm, 1.6 bars if patient's height is between 150 cm and 160 cm, 1.8 bars if patient's height is between 161 cm and 170 cm, 2.0 bars if patient's height is between 171 cm and 180 cm, 2.2 bars if patient's height is between 181 cm and 190 cm and 2.4 bars if patient's height > 190 cm
Receives: Procedure: High-Frequency Jet Ventilation (HFJV)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Efficacy on respiratory function of a personalized strategy for adjusting the driving pressure of the HFJV

    Occurrence of at least one of the following events :

    • Absolute change in FetCO2 of 8 mmHg between the baseline (T0) and the end of HFJV (T1), And/or
    • FetCO2 ≥ 45 mmHg at the end of the procedure, And/or
    • SpO2 < 94% at the end of the procedure, And/or
    • Interruption of HFJV before the end of the procedure due to SpO2 ≤ 90%.

    Measured: Immediately after the procedure

Secondary outcomes (14)
  1. Efficiency of the personalized setting compared to a fixed setting of 1.4 bars

    Occurrence of at least one of the four events comprising the main criterion, in the personalized setting group and in the fixed setting group of 1.4 bars

    Measured: Immediately after the procedure

  2. Efficiency of the personalized setting compared to a fixed setting of 1.9 bars

    Occurrence of at least one of the four events comprising the main criterion, in the personalized setting group and in the fixed setting group of 1.9 bars

    Measured: Immediately after the procedure

  3. Efficiency of the personalized setting compared to a fixed setting of 2.4 bars

    Occurrence of at least one of the four events comprising the main criterion in the personalized setting group and in the fixed setting group of 2.4 bars

    Measured: Immediately after the procedure

  4. Efficiency for each of the four events comprising the composite criterion of the customized setting compared to all three other groups

    Occurrence of each of the four events of the composite criterion in the personalized setting group and in all three other groups

    Measured: Immediately after the procedure

  5. Efficiency for each of the four events comprising the composite criterion, of the customized setting compared to a fixed setting of 1.4 bars

    Occurrence of each of the four events of the composite criterion in the personalized setting group and in the fixed setting group of 1.4 bars

    Measured: Immediately after the procedure

  6. Efficiency for each of the four events comprising the composite criterion, of the customized setting compared to a fixed setting of 1.9 bars

    Occurrence of each of the four events of the composite criterion in the personalized setting group and in the fixed setting group of 1.9 bars

    Measured: Immediately after the procedure

  7. Efficiency for each of the four events comprising the composite criterion, of the customized setting compared to a fixed setting of 2.4 bars

    Occurrence of each of the four events of the composite criterion in the personalized setting group and in the fixed setting group of 2.4 bars

    Measured: Immediately after the procedure

  8. Risk factors for respiratory complications

    Patient and HFJV intervention characteristics associated with the occurrence of respiratory complications during JVHF at T1

    Measured: Immediately after the procedure

  9. Oxygen saturation

    Variation in SpO2

    Measured: Immediately after the procedure

  10. Nu-Desc score

    Change in the Nu-Desc score in the post-anesthesia care unit

    Measured: At day 0

  11. Patient's surgical pathway

    Duration in post-intervention care unit

    Measured: From time of randomization until the time of care unit discharge assessed up to one day

  12. Patient journey during the stay

    Duration of stay

    Measured: From time of randomization until the time of hospital discharge assessed up to one day

  13. Headache

    Occurence of headache in the post-anesthesia care unit

    Measured: At day 0

  14. Sweating

    Occurence of sweating in the post-anesthesia care unit

    Measured: At day 0

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Feb 2026
  2. Study start13 Mar 2026
  3. Primary completion13 Mar 2028 (estimated)
  4. Study completion13 Mar 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
560 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07408375
Sponsor's protocol ID
RC24_0606
Acronym
Pulmojet 3
Status last verified
Oct 2026
First submitted
21 Jan 2026
Last updated
19 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing High-Frequency Jet Ventilation (HFJV) in people with Solid Tumor (Excluding CNS), run by Nantes University Hospital at 7 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 19 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 7 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Nathalie DESFRICHES-DORIA (0244768434, nathalie.desfrichesdoria@chu-nantes.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Efficacy on respiratory function of a personalized strategy for adjusting the driving pressure of the HFJV (time frame: Immediately after the procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in